Use of a Self-guided Computerized Cognitive Behavioral Tool During COVID-19: Evaluation Study.

COVID-19 acceptability cognitive behavioral therapy computer-based therapy computerized cognitive behavioral therapy depression digital health effectiveness interactive media stress therapy usability

Journal

JMIR formative research
ISSN: 2561-326X
Titre abrégé: JMIR Form Res
Pays: Canada
ID NLM: 101726394

Informations de publication

Date de publication:
31 May 2021
Historique:
received: 06 01 2021
accepted: 07 05 2021
revised: 08 03 2021
pubmed: 12 5 2021
medline: 12 5 2021
entrez: 11 5 2021
Statut: epublish

Résumé

Internet-based programs can help provide accessible and inexpensive behavioral health care to those in need; however, the evaluation of these interventions has been mostly limited to controlled trials. Data regarding patterns of use and effectiveness of self-referred, open-access online interventions are lacking. We evaluated an online-based treatment designed to address stress, depression, and conflict management, the Dartmouth PATH Program, in a freely available and self-guided format during the COVID-19 pandemic. The primary aim is to determine users' levels of stress and depression, and the nature of problems and triggers they reported during the COVID-19 pandemic. A secondary objective is to assess the acceptability and usability of the PATH content and determine whether such a program would be useful as a stand-alone open-access resource. The final objective is understanding the high dropout rates associated with online behavioral programs by contrasting the use pattern and program efficacy of individuals who completed session one and did not return to the program with those who came back to complete more sessions. Cumulative anonymous data from 562 individuals were analyzed. Stress triggers, stress responses, and reported problems were analyzed using qualitative analysis techniques. Scores on usability and acceptability questionnaires were evaluated using the sign test and Wilcoxon signed rank test. Mixed-effects linear modeling was used to evaluate changes in stress and depression over time. A total of 2484 users registered from April through October 2020, most of whom created an account without initiating a module. A total of 562 individuals started the program and were considered in the data analysis. The most common stress triggers individuals reported involved either conflicts with family or spouses and work or workload. The most common problems addressed in the mood module were worry, anxiousness, or stress and difficulty concentrating or procrastination. The attrition rate was high with 13% (21/156) completing the conflict module, 17% (50/289) completing session one of the mood module, and 14% (16/117) completing session one of the stress module. Usability and acceptability scores for the mood and stress modules were significantly better than average. In those who returned to complete sessions, symptoms of stress showed a significant improvement over time (P=.03), and there was a significant decrease in depressive symptoms over all time points (P=.01). Depression severity decreased on average by 20% (SD 35.2%; P=.60) between sessions one and two. Conflicts with others, worry, and difficulty concentrating were some of the most common problems people used the programs to address. Individuals who completed the modules indicated improvements in self-reported stress and depression symptoms. Users also found the modules to be effective and rated the program highly for usability and acceptability. Nevertheless, the attrition rate was very high, as has been found with other freely available online-based interventions. ClinicalTrials.gov NCT02726061; https://clinicaltrials.gov/ct2/show/NCT02726061.

Sections du résumé

BACKGROUND BACKGROUND
Internet-based programs can help provide accessible and inexpensive behavioral health care to those in need; however, the evaluation of these interventions has been mostly limited to controlled trials. Data regarding patterns of use and effectiveness of self-referred, open-access online interventions are lacking. We evaluated an online-based treatment designed to address stress, depression, and conflict management, the Dartmouth PATH Program, in a freely available and self-guided format during the COVID-19 pandemic.
OBJECTIVE OBJECTIVE
The primary aim is to determine users' levels of stress and depression, and the nature of problems and triggers they reported during the COVID-19 pandemic. A secondary objective is to assess the acceptability and usability of the PATH content and determine whether such a program would be useful as a stand-alone open-access resource. The final objective is understanding the high dropout rates associated with online behavioral programs by contrasting the use pattern and program efficacy of individuals who completed session one and did not return to the program with those who came back to complete more sessions.
METHODS METHODS
Cumulative anonymous data from 562 individuals were analyzed. Stress triggers, stress responses, and reported problems were analyzed using qualitative analysis techniques. Scores on usability and acceptability questionnaires were evaluated using the sign test and Wilcoxon signed rank test. Mixed-effects linear modeling was used to evaluate changes in stress and depression over time.
RESULTS RESULTS
A total of 2484 users registered from April through October 2020, most of whom created an account without initiating a module. A total of 562 individuals started the program and were considered in the data analysis. The most common stress triggers individuals reported involved either conflicts with family or spouses and work or workload. The most common problems addressed in the mood module were worry, anxiousness, or stress and difficulty concentrating or procrastination. The attrition rate was high with 13% (21/156) completing the conflict module, 17% (50/289) completing session one of the mood module, and 14% (16/117) completing session one of the stress module. Usability and acceptability scores for the mood and stress modules were significantly better than average. In those who returned to complete sessions, symptoms of stress showed a significant improvement over time (P=.03), and there was a significant decrease in depressive symptoms over all time points (P=.01). Depression severity decreased on average by 20% (SD 35.2%; P=.60) between sessions one and two.
CONCLUSIONS CONCLUSIONS
Conflicts with others, worry, and difficulty concentrating were some of the most common problems people used the programs to address. Individuals who completed the modules indicated improvements in self-reported stress and depression symptoms. Users also found the modules to be effective and rated the program highly for usability and acceptability. Nevertheless, the attrition rate was very high, as has been found with other freely available online-based interventions.
TRIAL REGISTRATION BACKGROUND
ClinicalTrials.gov NCT02726061; https://clinicaltrials.gov/ct2/show/NCT02726061.

Identifiants

pubmed: 33973856
pii: v5i5e26989
doi: 10.2196/26989
pmc: PMC8168639
doi:

Banques de données

ClinicalTrials.gov
['NCT02726061']

Types de publication

Journal Article

Langues

eng

Pagination

e26989

Informations de copyright

©Isadora Detweiler Guarino, Devin R Cowan, Abigail M Fellows, Jay C Buckey. Originally published in JMIR Formative Research (https://formative.jmir.org), 31.05.2021.

Références

Br J Psychiatry. 2004 Jun;184:526-33
pubmed: 15172947
Am J Community Psychol. 1995 Dec;23(6):843-70
pubmed: 8638553
Aerosp Med Hum Perform. 2020 Nov 1;91(11):876-885
pubmed: 33334408
JMIR Res Protoc. 2012 Sep 25;1(2):e11
pubmed: 23611902
Behav Res Ther. 2013 Feb;51(2):106-12
pubmed: 23262118
Clin Psychol Rev. 2012 Jun;32(4):329-42
pubmed: 22466510
Arch Gen Psychiatry. 2005 Jun;62(6):617-27
pubmed: 15939839
J Health Soc Behav. 1983 Dec;24(4):385-96
pubmed: 6668417
World Psychiatry. 2014 Feb;13(1):4-11
pubmed: 24497236
Psychol Med. 2003 Feb;33(2):217-27
pubmed: 12622301
PLoS One. 2010 Oct 13;5(10):e13196
pubmed: 20967242
J Med Internet Res. 2011 Aug 05;13(3):e52
pubmed: 21821503
Br J Psychiatry. 2008 Feb;192(2):130-4
pubmed: 18245031
Aerosp Med Hum Perform. 2016;87(11):912-920
pubmed: 27779949
Cogn Behav Ther. 2009;38(4):196-205
pubmed: 20183695
JAMA. 1997 Jan 22-29;277(4):333-40
pubmed: 9002497
Behav Ther. 2017 May;48(3):413-425
pubmed: 28390503
J Med Internet Res. 2005 Jun 21;7(2):e16
pubmed: 15998607
Psychol Med. 2007 Sep;37(9):1217-28
pubmed: 17306044
Can J Psychiatry. 2019 Jul;64(7):465-470
pubmed: 31096757
J Med Internet Res. 2005 Mar 31;7(1):e11
pubmed: 15829473
J Med Internet Res. 2011 Mar 10;13(1):e30
pubmed: 21393123
Psychol Med. 2015 Oct;45(13):2717-26
pubmed: 25881626
J Med Internet Res. 2017 Sep 13;19(9):e309
pubmed: 28903893
J Med Internet Res. 2005 Mar 26;7(1):e7
pubmed: 15829479
Behav Ther. 2014 May;45(3):358-75
pubmed: 24680231
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Arch Gen Psychiatry. 2006 Aug;63(8):925-34
pubmed: 16894069
PLoS One. 2011;6(6):e21274
pubmed: 21712998
Br J Clin Psychol. 2010 Nov;49(Pt 4):455-71
pubmed: 19799804
J Med Internet Res. 2004 Dec 22;6(4):e46
pubmed: 15631970
Psychol Med. 2007 Mar;37(3):319-28
pubmed: 17112400

Auteurs

Isadora Detweiler Guarino (I)

Space Medicine Innovations Laboratory, Geisel School of Medicine at Dartmouth, Lebanon, NH, United States.

Devin R Cowan (DR)

Space Medicine Innovations Laboratory, Geisel School of Medicine at Dartmouth, Lebanon, NH, United States.

Abigail M Fellows (AM)

Space Medicine Innovations Laboratory, Geisel School of Medicine at Dartmouth, Lebanon, NH, United States.

Jay C Buckey (JC)

Space Medicine Innovations Laboratory, Geisel School of Medicine at Dartmouth, Lebanon, NH, United States.

Classifications MeSH